AMDL receives Israeli patent for animal model for the evaluation of vaccines AMDL viagra price.

AMDL receives Israeli patent for animal model for the evaluation of vaccines AMDL, Inc. CIT is certainly a technology owned by AMDL that may be useful in treating specific forms of cancer. AMDL also offers patents and patents pending declaring a novel model, and ways of using these versions, derived through the CIT technology it believes will be far more useful than animal research because AMDL’s ‘humanized’ mice have human-like immune systems viagra price . ‘Medical science is definitely worried about adverse occurrences in human being trials that are not predicted in traditional animal studies,’ said Gary Dreher, AMDL CEO.